Cresol Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 07-12-2024
- Paid Up Capital ₹ 0.70 M
as on 07-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 07-12-2024
- Revenue 1015.43%
(FY 2020)
- Profit 61.59%
(FY 2020)
- Ebitda 116.68%
(FY 2020)
- Net Worth -44.25%
(FY 2020)
- Total Assets 162.11%
(FY 2020)
About Cresol Pharmaceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹1.00 M.
Muthusamy Senthil, Subramanian Jayakumar, and Palanisamy Gurunavukkarasu serve as directors at the Company.
- CIN/LLPIN
U24304TN2018PTC125230
- Company No.
125230
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cresol Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthusamy Senthil  | Director | 12-Oct-2018 | Current |
| Subramanian Jayakumar | Director | 12-Oct-2018 | Current |
| Palanisamy Gurunavukkarasu | Director | 12-Oct-2018 | Current |
Financial Performance of Cresol Pharmaceuticals.
Cresol Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1015.43% increase. The company also saw a substantial improvement in profitability, with a 61.59% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cresol Pharmaceuticals?
Unlock access to Cresol Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Jun 2020 | ₹1.00 M | Open |
How Many Employees Work at Cresol Pharmaceuticals?
Unlock and access historical data on people associated with Cresol Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cresol Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cresol Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
